![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Vol. 58, Issue 5, 1026-1034, November 2000
Byk Gulden Pharmaceuticals, Konstanz, Germany
We have investigated various nitric oxide (NO) synthase inhibitors for
their affinity and selectivity toward the three human isoenzymes in
radioligand binding experiments. Therefore, we developed the new
radioligand [3H]2-amino-4-picoline to measure binding of
these compounds to the three human NO synthase (NOS) isoenzymes.
Aminopicoline is a potent and nonselective inhibitor of all three
isoforms. [3H]2-amino-4-picoline bound saturably and with
high affinity to human NOSs. Affinity constants
(KD values) of 59, 111, and 136 nM were
obtained for the inducible, neuronal, and endothelial NOS isoforms
(iNOS, nNOS, eNOS). Binding of [3H]2-amino-4-picoline was
competitive with the substrate arginine. From all the inhibitors
tested, AMT
(2-amino-5,6-dihydro-6-methyl-4H-1,3-thiazine hydrochloride) showed the highest affinity and no selectivity. L-NIL
[L-N6-(1-Iminoethyl)lysine
hydrochloride] and aminoguanidine were moderately iNOS-selective while
L-NA
(NG-nitro-L-arginine)
and L-NAME
(NG-nitro-L-arginine
methyl ester hydrochloride) showed selectivity toward the constitutive
isoforms. High iNOS versus eNOS selectivity was found for 1400W,
whereas several isothiourea derivatives and 1400W displayed moderate n-
versus eNOS selectivity. To relate the affinity of these compounds to
their inhibitory potency, we measured the inhibitory potency under
almost identical conditions using a new microtiter plate assay. The
inhibitory potency of selective and nonselective NOS inhibitors was
almost exactly mirrored by their affinity toward the different
isoenzymes. Highly significant correlations were obtained between the
potency of enzyme inhibition and the inhibition of
[3H]2-amino-4-picoline binding for all three
isoenzymes. These data show that the potency and selectivity of NOS
inhibitors are solely determined by their affinity toward the different
isoforms. Furthermore, these data identify the new radioligand
[3H]2-amino-4-picoline as a very useful
radiolabel for the investigation of the substrate binding site of all
three isoforms.
This article has been cited by other articles:
|
|
 |
|
  A.-S. Bhat, S. Kumar Tandan, D. Kumar, V. Krishna, and V. R. Prakash The Interaction Between Inhibitors of Nitric Oxide Synthase and Cyclooxygenase in Formalin-Induced Pain in Mice: An Isobolographic Study Anesth. Analg., March 1, 2008; 106(3): 978 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Wang, E. Zolty, S. Falk, S. Summer, Z. Zhou, P. Gengaro, S. Faubel, N. Alp, K. Channon, and R. Schrier Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1 Am J Physiol Renal Physiol, March 1, 2008; 294(3): F571 - F576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. El-Mas, M. Fan, and A. A. Abdel-Rahman Endotoxemia-Mediated Induction of Cardiac Inducible Nitric-Oxide Synthase Expression Accounts for the Hypotensive Effect of Ethanol in Female Rats J. Pharmacol. Exp. Ther., January 1, 2008; 324(1): 368 - 375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wu, N. Gokden, and P. R. Mayeux Evidence for the Role of Reactive Nitrogen Species in Polymicrobial Sepsis-Induced Renal Peritubular Capillary Dysfunction and Tubular Injury J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1807 - 1815. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Cobine, B. P. Callaghan, and K. D. Keef Role of L-type calcium channels and PKC in active tone development in rabbit coronary artery Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3079 - H3088. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Piotrkowski, C. G. Fraga, and E. M. V. de Cavanagh Mitochondrial function and nitric oxide metabolism are modified by enalapril treatment in rat kidney Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1494 - R1501. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Martin, R. Schulz, H. Post, K. Boengler, M. Kelm, P. Kleinbongard, P. Gres, A. Skyschally, I. Konietzka, and G. Heusch Microdialysis-based analysis of interstitial NO in situ: NO synthase-independent NO formation during myocardial ischemia Cardiovasc Res, April 1, 2007; 74(1): 46 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J W Ferguson, A R Dover, S Chia, N L M Cruden, P C Hayes, and D E Newby Inducible nitric oxide synthase activity contributes to the regulation of peripheral vascular tone in patients with cirrhosis and ascites Gut, April 1, 2006; 55(4): 542 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. J. Hurt, S. F. Sezen, H. C. Champion, J. K. Crone, M. A. Palese, P. L. Huang, A. Sawa, X. Luo, B. Musicki, S. H. Snyder, et al. Alternatively spliced neuronal nitric oxide synthase mediates penile erection PNAS, February 28, 2006; 103(9): 3440 - 3443. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Strub, W.-R. Ulrich, C. Hesslinger, M. Eltze, T. Fuchss, J. Strassner, S. Strand, M. D. Lehner, and R. Boer The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase Mol. Pharmacol., January 1, 2006; 69(1): 328 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. W. Wood, R. C. Hastings, and L. A. Sygowski A Homogeneous Fluorescent Cell-Based Assay for Detection of Heterologously Expressed Nitric Oxide Synthase Activity J Biomol Screen, December 1, 2005; 10(8): 849 - 855. [Abstract] [PDF]
|
|
|
|
 |
|
 S. Pouvreau and V. Jacquemond Nitric oxide synthase inhibition affects sarcoplasmic reticulum Ca2+ release in skeletal muscle fibres from mouse J. Physiol., September 15, 2005; 567(3): 815 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Hodges, M. A. Shatos, R. S. Tarko, J. Vrouvlianis, J. Gu, and D. A. Dartt Nitric Oxide and cGMP Mediate {alpha}1D-Adrenergic Receptor-Stimulated Protein Secretion and p42/p44 MAPK Activation in Rat Lacrimal Gland Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2781 - 2789. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Zhang, A. Beuve, and E. Townes-Anderson The Nitric Oxide-cGMP Signaling Pathway Differentially Regulates Presynaptic Structural Plasticity in Cone and Rod Cells J. Neurosci., March 9, 2005; 25(10): 2761 - 2770. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hongo, J. S. Bryson, A. M. Kaplan, and D. A. Cohen Endogenous Nitric Oxide Protects against T Cell-Dependent Lethality during Graft-versus-Host Disease and Idiopathic Pneumonia Syndrome J. Immunol., August 1, 2004; 173(3): 1744 - 1756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. L. Cummings and R. L. Tarleton Inducible Nitric Oxide Synthase Is Not Essential for Control of Trypanosoma cruzi Infection in Mice Infect. Immun., July 1, 2004; 72(7): 4081 - 4089. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ishikawa and R. M. Quock Role of Nitric-Oxide Synthase Isoforms in Nitrous Oxide Antinociception in Mice J. Pharmacol. Exp. Ther., August 1, 2003; 306(2): 484 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. V. Rossoni, M. Salaices, M. Miguel, A. M. Briones, L. A. Barker, D. V. Vassallo, and M. J. Alonso Ouabain-induced hypertension is accompanied by increases in endothelial vasodilator factors Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2110 - H2118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. A. Murray, I. Daniels, K. Coupland, J. A. Smith, and R. G. Long Increased activity and expression of iNOS in human duodenal enterocytes from patients with celiac disease Am J Physiol Gastrointest Liver Physiol, August 1, 2002; 283(2): G319 - G326. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Gumpricht, R. Dahl, B. Yerushalmi, M. W. Devereaux, and R. J. Sokol Nitric Oxide Ameliorates Hydrophobic Bile Acid-induced Apoptosis in Isolated Rat Hepatocytes by Non-mitochondrial Pathways J. Biol. Chem., July 5, 2002; 277(28): 25823 - 25830. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Haitsma, D. Merkus, J. Vermeulen, P. D. Verdouw, and D. J. Duncker Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2198 - H2209. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Thienel, K. Chwalisz, and E. Winterhager Expression of MAPkinases (Erk1/2) during decidualization in the rat: regulation by progesterone and nitric oxide Mol. Hum. Reprod., May 1, 2002; 8(5): 465 - 474. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Ishibashi, T. Shimada, Y. Murakami, N. Takahashi, T. Sakane, T. Sugamori, S. Ohata, S.-i. Inoue, Y. Ohta, K. Nakamura, et al. An inhibitor of inducible nitric oxide synthase decreases forearm blood flow in patients with congestive heart failure J. Am. Coll. Cardiol., November 1, 2001; 38(5): 1470 - 1476. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. Krieglstein, W. H. Cerwinka, F. S. Laroux, J. W. Salter, J. M. Russell, G. Schuermann, M. B. Grisham, C. R. Ross, and D. N. Granger Regulation of Murine Intestinal Inflammation by Reactive Metabolites of Oxygen and Nitrogen: Divergent Roles of Superoxide and Nitric Oxide J. Exp. Med., October 29, 2001; 194(9): 1207 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. B. Haitsma, D. Merkus, J. Vermeulen, P. D. Verdouw, and D. J. Duncker Nitric oxide production is maintained in exercising swine with chronic left ventricular dysfunction Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2198 - H2209. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
